Ex Parte GOVINDAN et al - Page 5



              Appeal No. 2001-0758                                                               Page 5                
              Application No. 08/919,477                                                                               
              DTPA).”  Answer, pages 8 and 9.  It is not clear what the basis for the examiner’s                       
              assertion is, and the actual statement of the rejection (Answer, pages 4-7) says nothing                 
              about the broad linker limitation,3 focusing instead on the limitations of narrower claims               
              19 and 20.  The last word on this issue is appellants’ blanket assertion in the Reply                    
              Brief (page 3), that “Barbet does not teach or suggest a [linker] group for covalent                     
              attachment to an antibody.”                                                                              
                     The findings of fact underlying an obviousness rejection, as well as conclusions                  
              of law, must be made in accordance with the Administrative Procedure Act, 5 U.S.C.                       
              706 (A),(E) (1994).  See Zurko v. Dickinson, 527 U.S. 150, 158, 119 S.Ct. 1816, 1821,                    
              50 USPQ2d 1930, 1934 (1999).  Findings of fact underlying the obviousness rejection                      
              must be supported by substantial evidence within the record.  See In re Gartside, 203                    
              F.3d 1305, 1315, 53 USPQ2d 1769, 1775 (Fed. Cir. 2000).  In addition, in order for                       
              meaningful appellate review to occur, the examiner must present a full and reasoned                      
              explanation of the rejection.  See, e.g., In re Lee, 277 F.3d 1338, 1342, 61 USPQ2d                      
              1430, 1432 (Fed. Cir. 2002).  We would further emphasize what should be self-evident:                    
              the examiner must present a full and reasoned explanation of the rejection in the                        
              statement of the rejection, specifically identifying underlying facts and any supporting                 
              evidence, in order for appellants to have a fair and meaningful opportunity to respond.                  
              Clearly, the examiner’s rejection does not meet this standard, but we are reluctant to                   
              simply reverse the examiner’s decision on this basis alone.                                              
                     In our view, the examiner’s belated assertion that “[t]he linker limitation is met by             
              [Barbet’s N-alpha] DTPA” (Answer, page 9), “which can act as a linking group” (Answer,                   

                     3 We note that the examiner uses the phrase “peptide linker” in the statement of the rejection, but
              in every case, the phrase refers to the peptidyl portion of Barbet’s aminopolycarboxylate-appended       
              peptide, not to any “linker group” within the meaning of the claims at issue.                            



Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007